EMA Authorised: Dovprela (previously Pretomanid FGK) (pretomanid) — Mylan IRE Healthcare Limited

View source ↗

Summary

EMA authorised Dovprela (pretomanid) for multidrug-resistant tuberculosis; orphan medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• Dovprela (pretomanid)

Snippet

Status: Authorised. Therapeutic area: Tuberculosis, Multidrug-Resistant. MAH: Mylan IRE Healthcare Limited. Decision date: 04/05/2026. Orphan medicine